文献速递神经肿瘤

低强度脉冲超声开放血脑屏障用于中枢神经系统肿瘤的免疫调节与免疫治疗递送

Blood-brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors.
PubMed 文献 · J Neurooncol · 2020-02-28

本文综述了利用低强度脉冲超声开放血脑屏障以增强免疫治疗药物和效应细胞递送的临床前研究,并介绍了已启动的若干临床研究;基于分析提出最可能从该策略中获益的免疫治疗策略。文献检索使用Medline/PubMed数据库和临床试验注册库clinicaltrials.gov,并检索纳入文献的参考文献列表。

要点

  • 低强度脉冲超声可安全、高效地将小分子药物、抗体或NK细胞递送至脑内临床前模型。
  • 在多种啮齿类脑肿瘤模型中,该策略已显示肿瘤控制及生存期延长。
  • 超声诱导的血脑屏障破坏可能同时刺激先天性和细胞免疫应答。

核心结论

  • 超声开放血脑屏障近期已进入临床试验并取得令人鼓舞的结果,该策略与免疫治疗联合为脑肿瘤治疗开辟了新领域。

研究设计与样本

  • 综述文章,总结使用低强度脉冲超声开放血脑屏障以增强免疫治疗药物及效应细胞群体递送的临床前研究,以及若干已启动的临床研究。
  • 文献检索与试验数据研究使用Medline/PubMed数据库和临床试验注册库clinicaltrials.gov,并检索所有纳入文章的参考文献列表以寻找额外研究。

主要发现

  • 在临床前模型中,低强度脉冲超声已将包括小分子药物、抗体或NK细胞在内的多种免疫治疗药物安全、高效地递送至脑内。
  • 在啮齿类动物的不同类型脑肿瘤模型中,已证实肿瘤控制及生存期延长。
  • 超声诱导的血脑屏障破坏可能刺激先天性和细胞免疫应答。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Opening of the blood-brain barrier (BBB) by pulsed low intensity ultrasound has been developed during the last decade and is now recognized as a safe technique to transiently and repeatedly open the BBB. This non- or minimally invasive technique allows for a targeted and uniform dispersal of a wide range of therapeutic substances throughout the brain, including immune cells and antibodies. METHODS: In this review article, we summarize pre-clinical studies that have used BBB-opening by pulsed low intensity ultrasound to enhance the delivery of immune therapeutics and effector cell populations, as well as several recent clinical studies that have been initiated. Based on this analysis, we propose immune therapeutic strategies that are most likely to benefit from this strategy. The literature review and trial data research were performed using Medline/Pubmed databases and clinical trial registry www.clinicaltrials.gov . The reference lists of all included articles were searched for additional studies. RESULTS: A wide range of immune therapeutic agents, including small molecular weight drugs, antibodies or NK cells, have been safely and efficiently delivered to the brain with pulsed low intensity ultrasound in preclinical models, and both tumor control and increased survival have been demonstrated in different types of brain tumor models in rodents. Ultrasound-induced BBB disruption may also stimulate innate and cellular immune responses. CONCLUSIONS: Ultrasound BBB opening has just recently entered clinical trials with encouraging results, and the association of this strategy with immune therapeutics creates a new field of brain tumor treatment.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Beccaria K, Sabbagh A, de Groot J, et al. Blood-brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors. J Neurooncol. 2020. PMID: 32112296. doi:10.1007/s11060-020-03425-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。